Skip to main content
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.120
-0.090 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
4.130
+0.010 (0.24%)
After-hours: Apr 28, 2026, 7:32 PM EDT

X4 Pharmaceuticals Revenue

In the year 2025, X4 Pharmaceuticals had annual revenue of $35.11M with 1,273.21% growth. X4 Pharmaceuticals had revenue of $2.57M in the quarter ending December 31, 2025, with 79.08% growth.

Revenue (ttm)
$35.11M
Revenue Growth
+1,273.21%
P/S Ratio
10.67
Revenue / Employee
$780,289
Employees
45
Market Cap
374.59M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202535.11M32.56M1,273.21%
Dec 31, 20242.56M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
Autolus Therapeutics 75.39M
Enanta Pharmaceuticals 66.98M
Lineage Cell Therapeutics 14.56M
Opus Genetics 14.20M
Silence Therapeutics 559.00K
YD Bio 510.36K
Avalo Therapeutics 59.00K
Revenue Rankings

XFOR News

More News